Sound Off for September 22nd: What do you think of CEO’s 5,000% price hike on AIDS & cancer drug?
The 32-year-old CEO of Turing Pharmaceuticals is at the center of a growing controversy over alleged “price gouging” by drug makers.
Martin Shkreli’s company raised the price of a drug called Daraprim from $13.50 a pill to $750 dollars a pill…overnight.
The drug is used by some AIDS and cancer patients. It’s main use is to treat life-threatening parasitic infections. It’s been around for 62 years, but Shkreli’s company bought the rights to it in August.
After the price hike, the Daily Beast declared Shkreli the “most-hated man” in America.
Hillary Clinton called out Turing Pharmaceuticals and other drug makers on Twitter for jacking up prices on old drugs.
Shkreli responded, saying Twitter, quote, “seems to be a great medium for socialist and liberal rage'” and called the price hike on Daraprim “a great thing for society.”
What do you think?
You can also email your response to firstname.lastname@example.org